Kodiak Sciences (KOD) Other Non-Current Assets (2017 - 2026)
Kodiak Sciences (KOD) posted Other Non-Current Assets of $6.2 million for Q1 2026, little changed on a QoQ basis from $6.2 million in Q4 2025, and little changed year-over-year from $6.2 million in Q1 2025.
Kodiak Sciences (KOD) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Kodiak Sciences' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $6.2 million for Q1 2026.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (changed 0.0% YoY) and the FY2025 annual result came in at $6.2 million, changed 0.0% from the prior year.
- Other Non-Current Assets was $6.2 million for Q1 2026 at Kodiak Sciences, roughly flat from $6.2 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $8.7 million in Q3 2025 and bottomed at $6.2 million in Q1 2024.
- A 5-year average of $6.5 million and a median of $6.3 million in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets declined 2.21% — and 2025, when it surged 40.28%.
- Kodiak Sciences' Other Non-Current Assets stood at $6.3 million in 2022, then changed by 0.0% to $6.3 million in 2023, then fell by 2.21% to $6.2 million in 2024, then changed by 0.0% to $6.2 million in 2025, then changed by 0.0% to $6.2 million in 2026.
- Business Quant data shows KOD's Other Non-Current Assets at $6.2 million in Q1 2026, $6.2 million in Q4 2025, and $8.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | 6.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.18 Mn |
| Dec 31, 2025 | 6.18 Mn |
| Sep 30, 2025 | 8.68 Mn |
| Jun 30, 2025 | 8.66 Mn |
| Mar 31, 2025 | 6.18 Mn |
| Dec 31, 2024 | 6.18 Mn |
| Sep 30, 2024 | 6.18 Mn |
| Jun 30, 2024 | 6.18 Mn |
| Mar 31, 2024 | 6.18 Mn |
| Dec 31, 2023 | 6.32 Mn |
| Sep 30, 2023 | 6.32 Mn |
| Jun 30, 2023 | 6.32 Mn |
| Mar 31, 2023 | 6.32 Mn |
| Dec 31, 2022 | 6.32 Mn |
| Sep 30, 2022 | 6.32 Mn |
| Jun 30, 2022 | 6.32 Mn |
| Mar 31, 2022 | 6.32 Mn |
| Dec 31, 2021 | 6.32 Mn |
| Sep 30, 2021 | 6.32 Mn |
| Jun 30, 2021 | 6.32 Mn |